Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Non-Current Assets: 2014-2020

Historic Other Non-Current Assets for vTv Therapeutics (VTVT) over the last 5 years, with Jun 2020 value amounting to $444,000.

  • vTv Therapeutics' Other Non-Current Assets fell 82.24% to $444,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $444,000, marking a year-over-year decrease of 82.24%. This contributed to the annual value of $2.5 million for FY2019, which is negligibly% changed negligibly from last year.
  • As of Q2 2020, vTv Therapeutics' Other Non-Current Assets stood at $444,000, which was down 82.24% from $2.5 million recorded in Q1 2020.
  • In the past 5 years, vTv Therapeutics' Other Non-Current Assets registered a high of $2.5 million during Q4 2017, and its lowest value of $444,000 during Q2 2020.
  • In the last 3 years, vTv Therapeutics' Other Non-Current Assets had a median value of $2.5 million in 2020 and averaged $2.3 million.
  • Per our database at Business Quant, vTv Therapeutics' Other Non-Current Assets rose by 29.27% in 2017 and then plummeted by 82.24% in 2020.
  • vTv Therapeutics' Other Non-Current Assets (Quarterly) stood at $1.9 million in 2016, then grew by 29.27% to $2.5 million in 2017, then remained steady at $2.5 million in 2018, then remained steady at $2.5 million in 2019, then tumbled by 82.24% to $444,000 in 2020.
  • Its last three reported values are $444,000 in Q2 2020, $2.5 million for Q1 2020, and $2.5 million during Q4 2019.